Drug Discovery News and Research

RSS
The drug discovery process begins with recognizing a disease or clinical condition in which there is a lack of adequate medical treatment. Once a potential drug has been identified, pre-clinical research can begin. This process includes several stages; the first of which involves identifying and validating the prospective drug’s target through assay development, high throughput screening, hit identification and finally, lead optimization. Once the pre-clinical process is complete, the newly synthesized drug candidate is selected for future clinical development.
Cancer Research UK invests £16 million in new Drug Discovery Programes at Manchester and Glasgow

Cancer Research UK invests £16 million in new Drug Discovery Programes at Manchester and Glasgow

Drug registration process for Nutra Pharma's pain reliever begins

Drug registration process for Nutra Pharma's pain reliever begins

Neurodegenerative disorders are the second-leading cause of early-onset dementia, says report

Neurodegenerative disorders are the second-leading cause of early-onset dementia, says report

Cyntellect releases new cell cytometry system

Cyntellect releases new cell cytometry system

Wyeth and Ambrx collaborate to produce the next generation of biologic drugs

Wyeth and Ambrx collaborate to produce the next generation of biologic drugs

Second-quarter 2009 unaudited results announced by Deltagen

Second-quarter 2009 unaudited results announced by Deltagen

Rexahn to sign licensing and stock purchase agreements with Teva Pharmaceutical

Rexahn to sign licensing and stock purchase agreements with Teva Pharmaceutical

New tool developed to provide precise and cost-effective data collection for drug discovery efforts

New tool developed to provide precise and cost-effective data collection for drug discovery efforts

Enzo expands its capability to perform simultaneous live-cell imaging of nuclear components

Enzo expands its capability to perform simultaneous live-cell imaging of nuclear components

Helicos Biosciences to raise $10 million through private placement

Helicos Biosciences to raise $10 million through private placement

Cyntellect announces commercial availability of Stem Cell Manager

Cyntellect announces commercial availability of Stem Cell Manager

Santaris Pharma establishes its operations in the U.S.

Santaris Pharma establishes its operations in the U.S.

LEAD Therapeutics' LT-29 antibiotic effective against most common antibiotic resistant bacteria

LEAD Therapeutics' LT-29 antibiotic effective against most common antibiotic resistant bacteria

Defective gene is linked to male infertility

Defective gene is linked to male infertility

New book on pharmacology launched

New book on pharmacology launched

Idera Pharmaceuticals to discuss TLR-targeted drug discovery and development programs

Idera Pharmaceuticals to discuss TLR-targeted drug discovery and development programs

Tripos announces a new program for software developers

Tripos announces a new program for software developers

Genova gains access to Big Pharma's distribution channels

Genova gains access to Big Pharma's distribution channels

IVIS Lumina XR in vivo imaging system from Caliper Life Sciences

IVIS Lumina XR in vivo imaging system from Caliper Life Sciences

CDI and VivoMedica launch pharmaceutical industry consortium

CDI and VivoMedica launch pharmaceutical industry consortium

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.